Buy or sell BostonGene stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
BostonGene is a biomedical software company for advanced patient analysis and personalized therapy in the fight against cancer.
About BostonGene Stock
BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene’s unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene’s mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies
President & CEO
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase